Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

IBM, Cal Tech, E-Patients, Qiagen, Digene, SABiosciences

DNA NANOCHIP IS GOAL OF IBM SCIENTISTS ADVANCES IN GENETIC AND MOLECULAR TECHNOLOGIES are giving pathologists new tools for diagnosing disease and guiding therapy. But what often receives less attention is how genetic and molecular technologies are finding applications in other scientific fields. In the September issue of Nature Nanotechnology, researchers at IBM Corp. and …

IBM, Cal Tech, E-Patients, Qiagen, Digene, SABiosciences Read More »

To access this post, you must purchase The Dark Report.



You are reading premium content from The Dark Report, your primary resource for running an efficient and profitable laboratory.

Get Unlimited Access to The Dark Report absolutely FREE!

You have read 0 of 1 of your complimentary articles this month

Privacy Policy: We will never share your personal information.